MedTrace Logo

Quality Control for Chronic Obstructive Pulmonary Disease

NCT03604146 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2021-02-10

No results posted yet for this study

Summary

This is a 1 year longitudinal study to establish a related index system for chronic obstructive pulmonary disease(COPD) quality control.Clinical and economic data of COPD patients will be collected and analyzed.

Conditions

Interventions

BEHAVIORAL

Medical quality control intervention strategy

Training and education for diagnosis, treatment and management of COPD for doctors and nurses; Regular inspection and supervision of medical quality

Sponsors & Collaborators

  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Principal Investigators

  • Rongchang Chen, MD · Guangzhou Institute of Respiratory Health,The First Affiliated Hospital of Guangzhou Medical University,China

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-20
Primary Completion
2020-06-30
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03604146 on ClinicalTrials.gov